VolitionRx Limited ("Volition"), a multi-national epigenetics company, today announces financial results and a business update for the third quarter of 2024. Volition management will host a conference ...
Concurrent with the closing of the public offering, the Company closed a private placement pursuant to which approximately $4.0 million in outstanding secured convertible notes originally issued in ...
Conference Call and Webcast Today at 4:30 p.m. ETDevelopment Program Highlights and Anticipated MilestonesOvaprene® hormone-free monthly ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback